Critical Care & Emergencies (all articles)
International study describes peri-intubation incidence of adverse events in critically ill patients
24 Mar, 2021 | 08:08h | UTCIntubation Practices and Adverse Peri-intubation Events in Critically Ill Patients From 29 Countries – JAMA (free for a limited period)
Editorial: International Variation in Intubation and Extubation Practices and Adverse Events Among Critically Ill Patients Receiving Mechanical Ventilation – JAMA (free for a limited period)
Observational study of invasive mechanical ventilation discontinuation showed weaning practices varied internationally
24 Mar, 2021 | 08:06h | UTCVentilator Weaning and Discontinuation Practices for Critically Ill Patients – JAMA (free for a limited period)
Editorial: International Variation in Intubation and Extubation Practices and Adverse Events Among Critically Ill Patients Receiving Mechanical Ventilation – JAMA (free for a limited period)
Systematic review: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection
25 Mar, 2021 | 08:38h | UTCCommentaries: Updated Cochrane review assesses how accurate rapid tests are for detecting COVID-19 – Wiley AND Expert reaction to updated Cochrane review of studies on accuracy of rapid tests (including lateral flow and molecular tests) to detect SARS-CoV-2 – Science Media Centre
NICE publishes single guideline for managing COVID-19
24 Mar, 2021 | 08:42h | UTCNews release: COVID-19 rapid guideline: managing COVID-19 – National Institute for Health and Care Excellence
Commentary on Twitter
Today NICE has published a single guideline for managing COVID-19, which brings together content from previous rapid COVID-19 guidance and evidence summaries. Read more: https://t.co/3O5yzpHK9e pic.twitter.com/DyD7lcLX8v
— NICE (@NICEComms) March 23, 2021
Review: Management of Staphylococcus aureus Bloodstream Infections
23 Mar, 2021 | 02:13h | UTCManagement of Staphylococcus aureus Bloodstream Infections – Frontiers in Medicine
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review
23 Mar, 2021 | 02:01h | UTC
WSES Position Paper: The management of surgical patients in the emergency setting during COVID-19 pandemic
24 Mar, 2021 | 08:39h | UTC
Study: More than half of antibiotics prescribed in US hospitals were not consistent with recommended prescribing practices
21 Mar, 2021 | 21:44h | UTCAssessment of the Appropriateness of Antimicrobial Use in US Hospitals
Commentary: New findings spur call to reduce improper antibiotic use in hospitals – CIDRAP
Commentary on Twitter
Newly published CDC data estimates that more than half of antibiotics prescribed in U.S. hospitals for selected prescribing events were not consistent with recommended prescribing practices. https://t.co/oZXNX26UiD pic.twitter.com/hUOrRxsPJG
— CDC Emerging Infections (@CDC_NCEZID) March 18, 2021
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
23 Mar, 2021 | 02:33h | UTCSARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia
Commentary on Twitter
Our research has underpinned key recommendations in new guidance on SARS-CoV-2 infection & elective surgery from @Assoc_Anaes & @RCoANews & @RCSnews.
This guideline can act as a template for policy makers in other countries!
🆓https://t.co/kKgJXFf0vd pic.twitter.com/mJRasJTJws
— COVIDSurg (@CovidSurg) March 20, 2021
EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomized clinical trials
23 Mar, 2021 | 02:30h | UTCRelated: FDA: Why you should not use Ivermectin to treat or prevent COVID-19 (statement, commentary, and RCT)
Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review
23 Mar, 2021 | 02:31h | UTC
Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study
23 Mar, 2021 | 02:20h | UTC
Commentary on Twitter
Lung #ultrasound based approach for early diagnosis of #COVID19 pneumonia:
➡️20 US/European hospitals
➡️1462 pts
Combining #LUS patterns of probability + clinical characteristics allow to rapidly rule in/out #SARSCoV2 pneumonia at bedside w high accuracy!https://t.co/GqsOZoIdgc pic.twitter.com/eENciXi9Cf— Intensive Care Medicine (@yourICM) March 20, 2021
Expert consensus statements for the management of COVID-19-related acute respiratory failure
21 Mar, 2021 | 22:05h | UTC
Commentary on Twitter
👌Expert consensus statements for the management of 👍💥 COVID-19-related acute respiratory failure using a Delphi method.
👇👇👇👇👇https://t.co/ujt8669VAb pic.twitter.com/AlT0ZkdKSc— RECAT👩🏽⚕️🏥👨🏽⚕️🇲🇽🫀 (@LeslieMegom) March 17, 2021
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
21 Mar, 2021 | 21:49h | UTC
Commentary on Twitter
@JACCJournals: We share a systematic summary of #anticcogulation,#antiplatelet, and #fibrinolysis #RCTs in #COVID19. Amazing work by @AzitaTalasaz and a stellar multidisciplinary team! Figs illustrate areas where we’ll have evidence, & the gaps. Link: https://t.co/t4ksxwjAze pic.twitter.com/0Th3OZBXOY
— Behnood Bikdeli (@bbikdeli) March 16, 2021
RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit
19 Mar, 2021 | 08:42h | UTCEditorial: Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 – JAMA
Commentary on Twitter
Intermediate-dose prophylactic enoxaparin (1 mg/kg/d) had no effect on a primary composite outcome of adjudicated venous or arterial thrombosis, ECMO, or 30-d mortality vs standard dose enoxaparin among ICU patients w #COVID19 https://t.co/L6UdB31J7V
— JAMA (@JAMA_current) March 18, 2021
Current evidence for COVID-19 therapies: a systematic literature review
19 Mar, 2021 | 08:36h | UTC
How do you treat coronavirus? Here are physicians’ best strategies
19 Mar, 2021 | 08:33h | UTCHow do you treat coronavirus? Here are physicians’ best strategies – Science (a few articles per month are free)
Video: Coronavirus Update with Carlos del Rio and Preeti Malani
19 Mar, 2021 | 08:24h | UTCCoronavirus Update With Carlos del Rio and Preeti Malani – JAMA
Review: Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke
18 Mar, 2021 | 08:54h | UTCDiagnosis and Management of Transient Ischemic Attack and Acute Ischemic Stroke: A Review – JAMA
The use of extracorporeal CO2 removal in acute respiratory failure
18 Mar, 2021 | 08:47h | UTCThe use of extracorporeal CO2 removal in acute respiratory failure – Annals of Intensive Care
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
18 Mar, 2021 | 09:05h | UTCThoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
Consensus Document: Management of acute myocarditis and chronic inflammatory cardiomyopathy
17 Mar, 2021 | 02:28h | UTC
A randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department
17 Mar, 2021 | 02:13h | UTCA randomized, noninferiority, controlled trial of two doses of intravenous subdissociative ketamine for analgesia in the emergency department – Academic Emergency Medicine (link to abstract – $ for full-text)
Commentaries: Lower dose of ketamine is as effective as the standard dose to treat pain in adults – Loyola University Health System AND Lower doses of ketamine shown to be non-inferior for acute pain control in the emergency setting – 2 Minute Medicine
FDA: Why you should not use Ivermectin to treat or prevent COVID-19
17 Mar, 2021 | 02:51h | UTCWhy You Should Not Use Ivermectin to Treat or Prevent COVID-19 – U.S. Food & Drug Administration
Commentary: FDA Rejects Ivermectin, Despite Growing Interest In Some Corners Of The Internet – Brief19
Related: RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies
17 Mar, 2021 | 02:52h | UTC
Commentary on Twitter
How common are pre‐existing heart & blood vessel problems in #COVID19? What are most common complications affecting heart & blood vessels in #COVID19? @CochraneHeart review of prevalence studies: https://t.co/rDqz2GyrpH
— The Cochrane Library (@CochraneLibrary) March 12, 2021